4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-25-018648
CIK 0001878313other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:13 PM ET
Size
5.2 KB
Accession
0001127602-25-018648
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2025-06-30+20,380→ 20,380 totalExercise: $1.80From: 2025-06-30Exp: 2035-06-30→ Common Stock (20,380 underlying)
Footnotes (1)
- [F1]The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:13 PM ET
- Size
- 5.2 KB